Maury Raycroft
Stock Analyst at Jefferies
(4.44)
# 1,171
Out of 4,609 analysts
234
Total ratings
44.1%
Success rate
12%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDTX Black Diamond Therapeutics | Maintained: Buy | $47 → $10 | $1.92 | +420.83% | 2 | Aug 6, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | $31 → $42 | $26.96 | +55.79% | 6 | Aug 5, 2026 | |
| KPTI Karyopharm Therapeutics | Maintained: Buy | $35 → $11 | $1.95 | +464.10% | 7 | Jul 31, 2026 | |
| ERAS Erasca | Rated: Buy | $21 → $24 | $18.27 | +31.36% | 3 | Jul 14, 2026 | |
| COAG Hemab Therapeutics Holdings | Maintained: Buy | $39 → $47 | $52.16 | -9.89% | 3 | Jul 13, 2026 | |
| TNGX Tango Therapeutics | Upgraded: Buy | $27 → $60 | $29.00 | +106.90% | 3 | Jun 26, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | $132 | $109.92 | +20.09% | 6 | Jun 15, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintained: Buy | $53 → $33 | $9.74 | +238.81% | 7 | May 12, 2026 | |
| BCYC Bicycle Therapeutics | Maintained: Buy | $12 | $3.97 | +202.27% | 1 | Apr 30, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $8 → $9 | $1.99 | +352.26% | 4 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $52 | $36.24 | +43.49% | 2 | Apr 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $39 → $56 | $45.40 | +23.35% | 4 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $15 | $5.18 | +189.58% | 7 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $1.80 | +1,455.56% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $20 | $4.70 | +325.53% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $21 | $16.13 | +30.19% | 16 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1.6 | $1.32 | +21.21% | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $384 → $549 | $216.12 | +154.03% | 35 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $15 | $9.30 | +61.29% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $27.25 | +50.46% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $35 | $62.45 | -43.96% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $79 | $93.25 | -15.28% | 3 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $23 | $12.93 | +77.88% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $3.5 | $0.9604 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $6.34 | n/a | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $9 | $2.95 | n/a | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $15 | $8.71 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $1.5 | $0.1115 | n/a | 8 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.3059 | n/a | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $1.24 | n/a | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $129 | $25.82 | n/a | 14 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $20 | $0.0001 | n/a | 5 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $27.01 | n/a | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.9024 | n/a | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 → $26 | $32.02 | n/a | 5 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $85.83 | n/a | 7 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $172 → $159 | $51.64 | n/a | 6 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 → $5 | $0.87 | n/a | 4 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $109 | $11.24 | n/a | 7 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $25 | $8.25 | n/a | 11 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $86 | $20.88 | n/a | 2 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $7.42 | n/a | 2 | May 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $16 | $64.55 | n/a | 6 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $6.90 | n/a | 2 | May 22, 2018 |
Black Diamond Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $47 → $10
Current: $1.92
Upside: +420.83%
Tyra Biosciences
Aug 5, 2026
Maintained: Buy
Price Target: $31 → $42
Current: $26.96
Upside: +55.79%
Karyopharm Therapeutics
Jul 31, 2026
Maintained: Buy
Price Target: $35 → $11
Current: $1.95
Upside: +464.10%
Erasca
Jul 14, 2026
Rated: Buy
Price Target: $21 → $24
Current: $18.27
Upside: +31.36%
Hemab Therapeutics Holdings
Jul 13, 2026
Maintained: Buy
Price Target: $39 → $47
Current: $52.16
Upside: -9.89%
Tango Therapeutics
Jun 26, 2026
Upgraded: Buy
Price Target: $27 → $60
Current: $29.00
Upside: +106.90%
Dianthus Therapeutics
Jun 15, 2026
Maintained: Buy
Price Target: $132
Current: $109.92
Upside: +20.09%
Corbus Pharmaceuticals Holdings
May 12, 2026
Maintained: Buy
Price Target: $53 → $33
Current: $9.74
Upside: +238.81%
Bicycle Therapeutics
Apr 30, 2026
Maintained: Buy
Price Target: $12
Current: $3.97
Upside: +202.27%
Compass Therapeutics
Apr 27, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $1.99
Upside: +352.26%
Apr 5, 2026
Maintained: Buy
Price Target: $14 → $52
Current: $36.24
Upside: +43.49%
Mar 26, 2026
Rated: Buy
Price Target: $39 → $56
Current: $45.40
Upside: +23.35%
Mar 23, 2026
Maintained: Buy
Price Target: $14 → $15
Current: $5.18
Upside: +189.58%
Feb 25, 2026
Maintained: Buy
Price Target: $28
Current: $1.80
Upside: +1,455.56%
Dec 8, 2025
Maintained: Buy
Price Target: $15 → $20
Current: $4.70
Upside: +325.53%
Nov 7, 2025
Upgraded: Buy
Price Target: $10 → $21
Current: $16.13
Upside: +30.19%
Oct 31, 2025
Downgraded: Hold
Price Target: $2 → $1.6
Current: $1.32
Upside: +21.21%
Oct 30, 2025
Maintained: Buy
Price Target: $384 → $549
Current: $216.12
Upside: +154.03%
Oct 14, 2025
Maintained: Buy
Price Target: $14 → $15
Current: $9.30
Upside: +61.29%
Oct 9, 2025
Initiated Coverage: Buy
Price Target: $41
Current: $27.25
Upside: +50.46%
Sep 10, 2025
Reiterated: Buy
Price Target: $38 → $35
Current: $62.45
Upside: -43.96%
Aug 15, 2025
Maintained: Buy
Price Target: $33 → $79
Current: $93.25
Upside: -15.28%
Aug 13, 2025
Maintained: Buy
Price Target: $40 → $23
Current: $12.93
Upside: +77.88%
Jun 24, 2025
Initiated Coverage: Hold
Price Target: $3.5
Current: $0.9604
Upside: n/a
Jun 11, 2025
Maintained: Buy
Price Target: $8
Current: $6.34
Upside: n/a
May 19, 2025
Maintained: Buy
Price Target: $15 → $9
Current: $2.95
Upside: n/a
May 16, 2025
Maintained: Buy
Price Target: $7 → $15
Current: $8.71
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $2 → $1.5
Current: $0.1115
Upside: n/a
Dec 6, 2024
Initiated Coverage: Buy
Price Target: $7
Current: $0.3059
Upside: n/a
Nov 13, 2024
Maintained: Buy
Price Target: $21
Current: $1.24
Upside: n/a
Oct 4, 2024
Rated: Buy
Price Target: $129
Current: $25.82
Upside: n/a
Apr 4, 2024
Maintained: Buy
Price Target: $10 → $20
Current: $0.0001
Upside: n/a
Mar 13, 2024
Initiated Coverage: Buy
Price Target: $6
Current: $27.01
Upside: n/a
Feb 8, 2024
Initiated Coverage: Buy
Price Target: $15
Current: $0.9024
Upside: n/a
Nov 9, 2023
Upgraded: Buy
Price Target: $6 → $26
Current: $32.02
Upside: n/a
Nov 29, 2022
Maintained: Buy
Price Target: $75
Current: $85.83
Upside: n/a
Sep 29, 2022
Reiterated: Buy
Price Target: $172 → $159
Current: $51.64
Upside: n/a
Dec 1, 2021
Downgraded: Hold
Price Target: $39 → $5
Current: $0.87
Upside: n/a
Jun 22, 2021
Maintained: Buy
Price Target: $37 → $109
Current: $11.24
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $14 → $25
Current: $8.25
Upside: n/a
Jul 29, 2020
Maintained: Buy
Price Target: $34 → $86
Current: $20.88
Upside: n/a
May 18, 2020
Maintained: Buy
Price Target: $25
Current: $7.42
Upside: n/a
Aug 10, 2018
Reiterated: Buy
Price Target: $9 → $16
Current: $64.55
Upside: n/a
May 22, 2018
Reiterated: Buy
Price Target: $28
Current: $6.90
Upside: n/a